Ergocalciferol 1,250 mcg Capsules — 8 Count / Taken Once A Week — Generic for Drisdol — Strides Pharma

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Ergocalciferol Capsules, USP contain vitamin D2. Each capsule contains 1.25 mg, which is equal to 50,000 USP Units. This medicine is a synthetic calcium regulator for oral use.

According to the label, ergocalciferol is used for hypoparathyroidism, refractory rickets (vitamin D resistant rickets), and familial hypophosphatemia. The label also states that the range between therapeutic and toxic doses is narrow, so dosing must be individualized under close medical supervision.

The label warns that vitamin D excess can cause serious harm, including high calcium levels and kidney, bone, soft tissue, and other effects. It also notes that this product contains FD&C Yellow No. 5, which may cause allergic-type reactions in some susceptible individuals.

Storage Information

protection of the fetus, therefore, the use of vitamin D in excess of the recommended dietary allowance during normal pregnancy should be avoided unless, in the judgment of the physician, potential benefits in a specific, unique case outweigh the significant hazards involved. Store at 20 to 25°C (68 to 77°F) [see USP Controlled Room Temperature].

Key Counseling Points

• Take this medicine exactly as prescribed because the range between therapeutic and toxic doses is narrow.
• Do not exceed the recommended dosage.
• Blood calcium and phosphorus may need to be checked regularly during treatment.
• Tell your healthcare professional about all vitamin D sources you use, including foods, supplements, self-administered products, and prescription drugs.
• Adequate dietary calcium is necessary for a clinical response to vitamin D therapy.
• This product contains FD&C Yellow No. 5 (tartrazine), which may cause allergic-type reactions in some susceptible individuals.
• Mineral oil may interfere with absorption of vitamin D preparations.
• Thiazide diuretics used with ergocalciferol in hypoparathyroid patients may cause hypercalcemia.
• Keep out of the reach of children.
• The label says to protect the product from light.

Helpful Patient Education

Ergocalciferol Capsules, USP are a prescription vitamin D2 product containing 50,000 USP Units per capsule. The label describes this medicine as a synthetic calcium regulator for oral administration and lists approved uses including hypoparathyroidism, refractory rickets, and familial hypophosphatemia.

This pharmacy information highlights label-based details such as dosing caution, monitoring for calcium and phosphorus, and the importance of avoiding vitamin D excess. Patients should also be aware that the product contains FD&C Yellow No. 5 and that the label instructs protection from light.

Medication Summary last generated: 2026-07-05 11:44:45